Gilead Sciences, the manufacturer of Truvada, is set to test components of the HIV prevention drug against COVID-19 as the pandemic continues to rage across the globe — but has low expectations for the results, a company spokesperson told the Washington Blade on Friday.
Sonia Choi, vice president for public affairs at Gilead Sciences, said via email the company plans to test components of the drug against coronaviruses in response to a Washington Blade inquiry on the use of the drugs against